Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence

Akueni L. Davelaar, Daniëlle Straub, Navtej Singh Buttar, Paul Fockens, Kausilia K. Krishnadath

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective. Molecular processes underlying Barrett's malignant development are poorly understood. Matrix metalloproteases (MMPs) are enzymes involved in inflammation, tissue remodeling, and malignant development. Therefore, active MMPs may have a role in early metaplasia development and Barrett's esophagus' malignant progression. We desired to gain more insight into the role of MMPs during the Barrett's esophagus pathogenesis sequence. Material and methods. In a surgical Barrett's mouse model, and in nonmalignant Barrett's and malignant esophageal cell lines, the activity of MMPs was investigated using a MMP activatable probe. MMP activity was further validated in Barrett's esophagus and esophageal adenocarcinoma patient biopsies and was further differentiated by investigating MMP9 and MMP13 expressions. Results. The mouse model showed probe activation in stromal cells early on in the esophagitis and metaplasia stages. MMP probe activation was higher in the Barrett's and cancer cell lines and biopsies as compared to normal cells and tissues. Co-immunostainings confirmed that, at the tissue level, the probe activation was mostly confined to CD45-positive stromal cells. MMP13 expression was highest in Barrett's metaplasia, whereas MMP9 was highest in the esophageal adenocarcinomas. Conclusion. During the Barrett's pathogenesis process, MMP activity is increased early on in the inflamed esophagus and remains high in metaplasia and esophageal adenocarcinoma. However, there is a switch of MMP13 to MMP9 expression once neoplasia develops. In the future, detecting specific MMP subtypes could be used for distinguishing nonmalignant from neoplastic Barrett's esophagus.

Original languageEnglish (US)
Pages (from-to)321-332
Number of pages12
JournalScandinavian Journal of Gastroenterology
Volume50
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Barrett Esophagus
Metalloproteases
Neoplasms
Metaplasia
Adenocarcinoma
Stromal Cells
Biopsy
Cell Line
Esophagitis
Esophagus
Inflammation

Keywords

  • Barrett's esophagus
  • Inflammation
  • Matrix metalloproteases

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence. / Davelaar, Akueni L.; Straub, Daniëlle; Buttar, Navtej Singh; Fockens, Paul; Krishnadath, Kausilia K.

In: Scandinavian Journal of Gastroenterology, Vol. 50, No. 3, 01.03.2014, p. 321-332.

Research output: Contribution to journalArticle

Davelaar, Akueni L. ; Straub, Daniëlle ; Buttar, Navtej Singh ; Fockens, Paul ; Krishnadath, Kausilia K. / Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence. In: Scandinavian Journal of Gastroenterology. 2014 ; Vol. 50, No. 3. pp. 321-332.
@article{a7207abc2f8a452baf6d4c2f70a3dcd0,
title = "Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence",
abstract = "Objective. Molecular processes underlying Barrett's malignant development are poorly understood. Matrix metalloproteases (MMPs) are enzymes involved in inflammation, tissue remodeling, and malignant development. Therefore, active MMPs may have a role in early metaplasia development and Barrett's esophagus' malignant progression. We desired to gain more insight into the role of MMPs during the Barrett's esophagus pathogenesis sequence. Material and methods. In a surgical Barrett's mouse model, and in nonmalignant Barrett's and malignant esophageal cell lines, the activity of MMPs was investigated using a MMP activatable probe. MMP activity was further validated in Barrett's esophagus and esophageal adenocarcinoma patient biopsies and was further differentiated by investigating MMP9 and MMP13 expressions. Results. The mouse model showed probe activation in stromal cells early on in the esophagitis and metaplasia stages. MMP probe activation was higher in the Barrett's and cancer cell lines and biopsies as compared to normal cells and tissues. Co-immunostainings confirmed that, at the tissue level, the probe activation was mostly confined to CD45-positive stromal cells. MMP13 expression was highest in Barrett's metaplasia, whereas MMP9 was highest in the esophageal adenocarcinomas. Conclusion. During the Barrett's pathogenesis process, MMP activity is increased early on in the inflamed esophagus and remains high in metaplasia and esophageal adenocarcinoma. However, there is a switch of MMP13 to MMP9 expression once neoplasia develops. In the future, detecting specific MMP subtypes could be used for distinguishing nonmalignant from neoplastic Barrett's esophagus.",
keywords = "Barrett's esophagus, Inflammation, Matrix metalloproteases",
author = "Davelaar, {Akueni L.} and Dani{\"e}lle Straub and Buttar, {Navtej Singh} and Paul Fockens and Krishnadath, {Kausilia K.}",
year = "2014",
month = "3",
day = "1",
doi = "10.3109/00365521.2014.940379",
language = "English (US)",
volume = "50",
pages = "321--332",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence

AU - Davelaar, Akueni L.

AU - Straub, Daniëlle

AU - Buttar, Navtej Singh

AU - Fockens, Paul

AU - Krishnadath, Kausilia K.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Objective. Molecular processes underlying Barrett's malignant development are poorly understood. Matrix metalloproteases (MMPs) are enzymes involved in inflammation, tissue remodeling, and malignant development. Therefore, active MMPs may have a role in early metaplasia development and Barrett's esophagus' malignant progression. We desired to gain more insight into the role of MMPs during the Barrett's esophagus pathogenesis sequence. Material and methods. In a surgical Barrett's mouse model, and in nonmalignant Barrett's and malignant esophageal cell lines, the activity of MMPs was investigated using a MMP activatable probe. MMP activity was further validated in Barrett's esophagus and esophageal adenocarcinoma patient biopsies and was further differentiated by investigating MMP9 and MMP13 expressions. Results. The mouse model showed probe activation in stromal cells early on in the esophagitis and metaplasia stages. MMP probe activation was higher in the Barrett's and cancer cell lines and biopsies as compared to normal cells and tissues. Co-immunostainings confirmed that, at the tissue level, the probe activation was mostly confined to CD45-positive stromal cells. MMP13 expression was highest in Barrett's metaplasia, whereas MMP9 was highest in the esophageal adenocarcinomas. Conclusion. During the Barrett's pathogenesis process, MMP activity is increased early on in the inflamed esophagus and remains high in metaplasia and esophageal adenocarcinoma. However, there is a switch of MMP13 to MMP9 expression once neoplasia develops. In the future, detecting specific MMP subtypes could be used for distinguishing nonmalignant from neoplastic Barrett's esophagus.

AB - Objective. Molecular processes underlying Barrett's malignant development are poorly understood. Matrix metalloproteases (MMPs) are enzymes involved in inflammation, tissue remodeling, and malignant development. Therefore, active MMPs may have a role in early metaplasia development and Barrett's esophagus' malignant progression. We desired to gain more insight into the role of MMPs during the Barrett's esophagus pathogenesis sequence. Material and methods. In a surgical Barrett's mouse model, and in nonmalignant Barrett's and malignant esophageal cell lines, the activity of MMPs was investigated using a MMP activatable probe. MMP activity was further validated in Barrett's esophagus and esophageal adenocarcinoma patient biopsies and was further differentiated by investigating MMP9 and MMP13 expressions. Results. The mouse model showed probe activation in stromal cells early on in the esophagitis and metaplasia stages. MMP probe activation was higher in the Barrett's and cancer cell lines and biopsies as compared to normal cells and tissues. Co-immunostainings confirmed that, at the tissue level, the probe activation was mostly confined to CD45-positive stromal cells. MMP13 expression was highest in Barrett's metaplasia, whereas MMP9 was highest in the esophageal adenocarcinomas. Conclusion. During the Barrett's pathogenesis process, MMP activity is increased early on in the inflamed esophagus and remains high in metaplasia and esophageal adenocarcinoma. However, there is a switch of MMP13 to MMP9 expression once neoplasia develops. In the future, detecting specific MMP subtypes could be used for distinguishing nonmalignant from neoplastic Barrett's esophagus.

KW - Barrett's esophagus

KW - Inflammation

KW - Matrix metalloproteases

UR - http://www.scopus.com/inward/record.url?scp=84922717635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922717635&partnerID=8YFLogxK

U2 - 10.3109/00365521.2014.940379

DO - 10.3109/00365521.2014.940379

M3 - Article

VL - 50

SP - 321

EP - 332

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 3

ER -